• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Physician attitudes regarding the risks, safe use, and regulations of long-acting or extended-release opioids for patients with chronic pain Product Image

Physician attitudes regarding the risks, safe use, and regulations of long-acting or extended-release opioids for patients with chronic pain

  • Published: November 2011
  • Region: United States
  • 41 Pages
  • CEOutcomes LLC

BACKGROUND AND PROJECT OVERVIEW

Hundreds of millions of Americans suffer from chronic pain, significantly reducing their quality of life. With this, opioid therapy is becoming more common, leading to increases in concern on issues of abuse and misuse. Additionally, the FDA recently released a statement notifying sponsors and manufacturers of long-acting and extended-release (LA/ER) opioids of the need to develop Risk Evaluation and Mitigation Strategies (REMS) programs in order to ensure the benefits of this therapy choice outweigh any potential risks. There is little research on the current processes physicians use when deciding when and how to counsel patients on the risks and safe use of opioid therapy, nor are there detailed studies on physician opinions of opioid-prescribing and education regulations. This paper presents initial data on the factors involved in the decision-making process of initiating a conversation about the risks and safe use of LA/ER opioids. Additionally, information is gathered on the attitudes surrounding new opioids regulations, including familiarity with the FDA-proposed REMS requirements.

STUDY OBJECTIVES

Based on the identified gaps READ MORE >

1. CONTEXT AND OBJECTIVES

2. DESIGN AND METHODS

3. SAMPLE DEMOGRAPHICS AND DESCRIPTIVE DATA

Discussing opioid risks and safe use with patients

Familiarity with and attitudes toward opioid regulations

Educational barriers to opioid prescription

4. FACTORS PREDICTING INITIATING A DISCUSSION REGARDING THE RISKS AND SAFE USE OF LA/ER OPIOID THERAPY

5. CONCLUSIONS AND IMPLICATIONS

APPENDIX A: SURVEY INSTRUMENT

APPENDIX B: COMPLETE DATA TABLES

APPENDIX C: REFERENCES

After a thorough literature review was conducted to ascertain the current attitudes and practice of physicians regarding opioid therapies, a survey was designed and distributed to primary care physicians (PCPs) through an online link in October 2011. Data collected from 201 PCPs were compiled for descriptive analysis and then analyzed to determine differences by various demographic groups. A logistic regression was run to determine the main predictors of initiating a discussion regarding the risks and safe use of long-acting or extended-release opioid therapy.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos